Scintigraphic Load of Bone Disease Evaluated by DASciS Software as a Survival Predictor in Metastatic Castration-resistant Prostate Cancer Patients Candidates to 223RaCl Treatment

BACKGROUND: Aim of our study was to assess the load of bone disease at starting and during Ra-223 treatment as an overall survival (OS) predictor in metastatic castration-resistant prostate cancer (mCRPC) patients. Bone scan index (BSI) is defined as the percentage of total amount of bone metastasis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiol Oncol
Main Authors: Frantellizzi, Viviana, Pani, Arianna, Ippoliti, Maria Dea, Farcomeni, Alessio, Aloise, Irvin, Colosi, Mirco, Polito, Claudia, Pani, Roberto, Vincentis, Giuseppe De
Formato: Artigo
Idioma:Inglês
Publicado em: Sciendo 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087429/
https://ncbi.nlm.nih.gov/pubmed/31855572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2019-0058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados